Oxygenta Pharmaceutical share news, announcements and annual reports
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹47.86.
30 Oct: open ₹47.01, high ₹48.21, low ₹46.89
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹175 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,027
Oxygenta Pharmaceutical share news and announcements
489 announcements, routine notices left out, newest first. Page 9 of 10.
Oct 2017
17 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....3 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2017
29 Sep · Meeting
Aug 2017
Jul 2017
21 Jul · Statement Of Investor Complaints
21 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
Jun 2017
22 Jun · Management
May 2017
Apr 2017
20 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....19 Apr · Certificate Under Reg. 40 (9) Of SEBI (LODR) Regulations, 2015
19 Apr · Certificate Under Reg.7 (3) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2017.
19 Apr · Statement Of Investor Complaints For The Quarter And Year Ended 31St March, 2017 Pursuant To Regulation 13(3) Of SEBI (LODR) Regulations, 2015.
Mar 2017
Feb 2017
Jan 2017
20 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
19 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
Oct 2016
22 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
17 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
Sep 2016
Aug 2016
Jul 2016
18 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....8 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
May 2016
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has approved the following Re-appointment for a period of 3 ....
Apr 2016
12 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....11 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mar 2016
23 Mar · Management
Mr. J. Vijay Kumar has filed his resignation due to his personal occupation and board of directors have approved the same in their meeting and he has ....
Feb 2016
Jan 2016
22 Jan · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....20 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Dec 2015
1 Dec · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from December 17, 2015 to December 24, 2015 (both days inclusive) ....
Nov 2015